Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2025-12-29 @ 5:01 AM
Study NCT ID:
NCT00038805
Status:
TERMINATED
Last Update Posted:
2018-10-31
First Post:
2002-06-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-05
Start Date Type:
None
Primary Completion Date:
2004-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-11
Completion Date Type:
ACTUAL
First Submit Date:
2002-06-05
First Submit QC Date:
None
Study First Post Date:
2002-06-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-30
Last Update Post Date:
2018-10-31
Last Update Post Date Type:
ACTUAL